CLINICAL_TRIALS
trial_result
· 2024-10-17
Clinical Trial Update: The FARAPULSE FARA-Freedom Trial [NA]
Summary
The FARAPULSE FARA-Freedom Trial evaluating pulsed field ablation for paroxysmal atrial fibrillation has completed. Results were posted on 2024-10-17.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2024-10-17